Peritoneocystic shunting for ascites.

Area of Science:

• Biomedical Engineering
• Surgical Innovation
• Medical Device Development

Background:

• Ascites, characterized by abdominal fluid accumulation, poses significant clinical challenges.
• Current treatments for tense ascites can be invasive and associated with complications.
• Novel fluid management devices are needed to improve patient outcomes.

Purpose of the Study:

• To evaluate the feasibility and efficacy of a prototype subcutaneously implanted peritoneocystic shunt.
• To assess the safety and functionality of the shunt in a preclinical animal model over a 1-month period.

Main Methods:

• A two-valve Denver shunt was surgically implanted in four swine under general anesthesia.
• The shunt's effectiveness was tested in vivo using normal saline irrigation.
• Animals were monitored for 1 month post-implantation, followed by explantation and pathological examination.

Main Results:

• All four swine survived the implantation and 1-month follow-up period.
• The peritoneocystic shunt maintained function in three out of four animals after 1 month.
• No calculi formation was observed; however, reactive inflammation was noted at the bladder insertion site.

Conclusions:

• The prototype peritoneocystic shunt demonstrated preliminary efficacy in fluid removal in a swine model.
• Subcutaneous implantation of a peritoneocystic shunt may represent a viable treatment option for tense ascites.
• Further investigation is warranted to optimize device design and assess long-term safety and efficacy.